Several observations have identified ZEB1 as a regulator in pancreatic Kras-driven carcinogenesis, demonstrating that Zeb1 deletion in the KPC mouse model significantly delayed the onset of pancreatic cancer with a remarkably low number of α-SMA+ fibroblasts [77,78]. The gene discussed is ZEB1; the disease is pancreatic neoplasm.